Noticias de Eulerpool Biohaven

Biohaven Noticias de Acciones

Biohaven es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Biohaven.

• 29 de mayo ·

  Yahoo
  Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor
• 29 de mayo ·

  Yahoo
  Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy
• 28 de mayo ·

  Yahoo
  Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)
• 28 de mayo ·

  Yahoo
  Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors
• 20 de mayo ·

  Fintel
  RBC Capital Downgrades Biohaven (BHVN)
• 15 de mayo ·

  Yahoo
  Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug
• 15 de mayo ·

  Yahoo
  Why Is Biohaven Stock Falling On Thursday?
• 9 de mayo ·

  Yahoo
  Biohaven Ltd. (BHVN): Among Stocks That Will Bounce Back According To Analysts
• 5 de mayo ·

  SeekingAlpha
  Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict
• 28 de abril ·

  Yahoo
  Biohaven Announces Investment up to $600 Million by Oberland Capital